{"filing":{"accession_number":"0001193125-26-253567","cik":"0001756655","ticker":"ARDT","company_name":"Ardent Health, Inc.","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"d854796d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1756655/000119312526253567/d854796d8k.htm"},"events":[{"id":7470,"run_id":6565,"accession_number":"0001193125-26-253567","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Dave Caspers was appointed as President and Chief Executive Officer and Board member of Ardent Health, Inc. effective June 2, 2026, succeeding Martin J. Bonick. The appointment includes an employment agreement and equity grants.","company_name":"Ardent Health, Inc.","ticker":"ARDT","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3584,"accession_number":"0001193125-26-253567","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of Dave Caspers as President and Chief Executive Officer and Board member effective June 2, 2026, succeeding Martin J. Bonick who separated from the Company. While the section also details Caspers' employment agreement and equity grants, the principal disclosed action is his appointment to the CEO role. This is material to investors as it represents a change in executive leadership and control of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:17:59.936575+00:00","company_name":"","ticker":null,"filing_date":""},{"id":3585,"accession_number":"0001193125-26-253567","item_number":"7.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"The Item 7.01 disclosure references \"the foregoing leadership transition\" and a press release, but the actual content of that transition is not provided in this excerpt. Without seeing the press release (Exhibit 99.1) or the preceding Item describing the transition, it is impossible to determine whether this is an exec_departure, exec_appointment, or another material event. The reference to a \"leadership transition\" suggests executive change, but the specific nature cannot be classified with confidence from this section alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:17:59.936575+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3584,"accession_number":"0001193125-26-253567","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of Dave Caspers as President and Chief Executive Officer and Board member effective June 2, 2026, succeeding Martin J. Bonick who separated from the Company. While the section also details Caspers' employment agreement and equity grants, the principal disclosed action is his appointment to the CEO role. This is material to investors as it represents a change in executive leadership and control of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:17:59.936575+00:00","company_name":"Ardent Health, Inc.","ticker":"ARDT","filing_date":"2026-06-02"},{"id":3585,"accession_number":"0001193125-26-253567","item_number":"7.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"The Item 7.01 disclosure references \"the foregoing leadership transition\" and a press release, but the actual content of that transition is not provided in this excerpt. Without seeing the press release (Exhibit 99.1) or the preceding Item describing the transition, it is impossible to determine whether this is an exec_departure, exec_appointment, or another material event. The reference to a \"leadership transition\" suggests executive change, but the specific nature cannot be classified with confidence from this section alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:17:59.936575+00:00","company_name":"Ardent Health, Inc.","ticker":"ARDT","filing_date":"2026-06-02"}]}